Practical methods using boronic acid compounds for identification of class C β-lactamase-producing Klebsiella pneumoniae and Escherichia coli

被引:139
作者
Yagi, T [1 ]
Wachino, J [1 ]
Kurokawa, H [1 ]
Suzuki, S [1 ]
Yamane, K [1 ]
Doi, Y [1 ]
Shibata, N [1 ]
Kato, H [1 ]
Shibayama, K [1 ]
Arakawa, Y [1 ]
机构
[1] Natl Inst Infect Dis, Dept Bacterial Pathogenesis & Infect Control, Tokyo 2080011, Japan
关键词
D O I
10.1128/JCM.43.6.2551-2558.2005
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Detection of the resistance mediated by class C beta-lactamases remains a challenging issue, considering that transferable plasmid-mediated class C beta-lactamases are of worldwide concern. Methods for the identification of strains that produce extended-spectrum beta-lactamases (ESBLs) or metallo-beta-lactamases (MBLs) have been developed and applied for routine use in clinical microbiology laboratories, but no practical methods for identification of plasmid-mediated class C producers have been established to date. We therefore developed three simple methods for clinical microbiology laboratories that allow identification of plasmid-mediated class C beta-lactamase-producing bacteria using a boronic acid derivative, 3-aminophenylboronic acid (APB), one of the specific inhibitors of class C beta-lactamases. Detection by the disk potentiation test was based on the enlargement of the growth-inhibitory zone diameter (by greater than or equal to 5 mm) around a Kirby-Bauer disk containing a ceftazidime (CAZ) or a cefotaxime (CTX) disk in combination with APB. In a double-disk synergy test, the discernible expansion of the growth-inhibitory zone around the CAZ or the CTX disk toward a disk containing APB was indicative of class C beta-lactamase production. A greater than or equal to eightfold decrease in the MIC of CAZ or CTX in the presence of APB was the criterion for detection in the microdilution test. By using these methods, Escherichia coli and Klebsiella pneumoniae isolates producing plasmid-mediated class C beta-lactamases, ACT-1, CMY-2, CMY-9, FOX-5, LAT-1, and MOX-1, were successfully distinguished from those producing other classes of beta-lactamases, such as ESBLs and MBLs. These methods will provide useful information needed for targeted antimicrobial therapy and better infection control.
引用
收藏
页码:2551 / 2558
页数:8
相关论文
共 45 条
  • [1] Arakawa Y, 2000, J CLIN MICROBIOL, V38, P40
  • [2] Salmonella enteritidis:: AmpC plasmid-mediated inducible β-lactamase (DHA-1) with an ampR gene from Morganella morganii
    Barnaud, G
    Arlet, G
    Verdet, C
    Gaillot, O
    Lagrange, PH
    Philippon, A
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (09) : 2352 - 2358
  • [3] EXTENDED BROAD-SPECTRUM BETA-LACTAMASE IN KLEBSIELLA PNEUMONIAE INCLUDING RESISTANCE TO CEPHAMYCINS
    BAUERNFEIND, A
    CHONG, Y
    SCHWEIGHART, S
    [J]. INFECTION, 1989, 17 (05) : 316 - 321
  • [4] THE INHIBITION OF CLASS-C BETA-LACTAMASES BY BORONIC ACIDS
    BEESLEY, T
    GASCOYNE, N
    KNOTTHUNZIKER, V
    PETURSSON, S
    WALEY, SG
    JAURIN, B
    GRUNDSTROM, T
    [J]. BIOCHEMICAL JOURNAL, 1983, 209 (01) : 229 - 233
  • [5] Use of β-lactamase inhibitors in disk tests to detect plasmid-mediated AmpC β-lactamases
    Black, JA
    Thomson, KS
    Pitout, JDD
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (05) : 2203 - 2206
  • [6] Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the loss of an outer membrane protein
    Bradford, PA
    Urban, C
    Mariano, N
    Projan, SJ
    Rahal, JJ
    Bush, K
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (03) : 563 - 569
  • [7] A FUNCTIONAL CLASSIFICATION SCHEME FOR BETA-LACTAMASES AND ITS CORRELATION WITH MOLECULAR-STRUCTURE
    BUSH, K
    JACOBY, GA
    MEDEIROS, AA
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (06) : 1211 - 1233
  • [8] Aza-boronic acids as non-β-lactam inhibitors of AmpC-β-lactamase
    Buzzoni, V
    Blazquez, J
    Ferrari, S
    Calò, S
    Venturelli, A
    Costi, MP
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (15) : 3979 - 3983
  • [9] Occurrence and detection of AmpC beta-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a Veterans Medical Center
    Coudron, PE
    Moland, ES
    Thomson, KS
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (05) : 1791 - 1796
  • [10] Inhibitor-sensitive AmpC β-lactamase variant produced by an Escherichia coli clinical isolate resistant to oxyiminocephalosporins and cephamycins
    Doi, Y
    Wachino, J
    Ishiguro, M
    Kurokawa, H
    Yamane, K
    Shibata, N
    Shibayama, K
    Yokoyama, K
    Kato, H
    Yagi, T
    Arakawa, Y
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (07) : 2652 - 2658